Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson’s disease.

Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson’s disease.
Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson's disease. Brain. 2019 Oct 11;: Authors: McCoy B, Jahfari S, Engels G, Knapen T, Theeuwes J Abstract Reduced levels of dopamine in Parkinson's disease contribute to changes in learning, resulting from the loss of midbrain neurons that transmit a dopaminergic teaching signal to the striatum. Dopamine medication used by patients ... read more
Source: PubMedPublished on 2019-10-12